Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2019 Evolving Medicaid Coverage Policy and Rebates Jennifer A. Ohn, MPH and Anna Kaltenboeck, MA Ethics questions arise about the usefulness of a system that pegs Medicaid drug spending to net prices negotiated by others in the market. AMA J Ethics. 2019;21(8):E645-653. doi: 10.1001/amajethics.2019.645. Policy Forum Aug 2019 Should a Law Governing the Pharmaceutical Market Be Ethically Examined Based on Its Intent or Its Practical Applications? Jordan M. Warchol, MD, MPH In 1984, Hatch-Waxman tried to balance drug innovation against availability; it was tested in the US Supreme Court in 2013. AMA J Ethics. 2019;21(8):E661-667. doi: 10.1001/amajethics.2019.661. Policy Forum Aug 2019 Why Are Biosimilars Not Living up to Their Promise in the US? Mike Z. Zhai, Ameet Sarpatwari, JD, PhD, and Aaron S. Kesselheim, MD, JD, MPH Overall utilization of the few biosimilars currently available to patients has been limited. AMA J Ethics. 2019;21(8):E668-678. doi: 10.1001/amajethics.2019.668. Medical Education Aug 2019 How Should Medical Education Better Prepare Physicians for Opioid Prescribing? Rohanit Singh and Gary W. Pushkin, MD Case-based teaching, longitudinal application, and training in ethical deliberation can better prepare physicians to responsibly prescribe and manage opioids. AMA J Ethics. 2019;21(8):E636-641. doi: 10.1001/amajethics.2019.636. AMA Code Says Aug 2019 AMA Code of Medical Ethics’ Opinions Related to Prescription Drugs Rachel F. Harbut and Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics offers guidance on stewardship and professionalism. AMA J Ethics. 2019;21(8):E642-644. doi: 10.1001/amajethics.2019.642. State of the Art and Science Aug 2019 Are Medicaid Closed Formularies Unethical? Leah Rand, DPhil and Govind Persad, JD, PhD Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients. AMA J Ethics. 2019;21(8):E654-660. doi: 10.1001/amajethics.2019.654. Medical Education Sep 2019 Facilitating Critical Self-Exploration by Global Health Students William B. Ventres, MD, MA Awareness of one’s own interests is critical to successfully engaging in global health immersions. AMA J Ethics. 2019;21(9):E749-758. doi: 10.1001/amajethics.2019.749. Policy Forum Sep 2019 How Should Public Health Schools Help Meet Millennium Development Goals in Latin America? Taryn Clark, MD, Julia Terle, MD, and Robert H. Gilman, MD Four MDGs directly concern public health, and public health schools should be involved in meeting them. AMA J Ethics. 2019;21(9):E788-795. doi: 10.1001/amajethics.2019.788. Case and Commentary Sep 2019 What Are Criteria for Considering Technologies’ Uses and Influences in LMICs’ Health Care Infrastructures? Rolvix Patterson and Richard Rohrer, MD Low-resource areas are heterogeneous and changing, so establishing an evidence base for decision making about technology use is an important priority. AMA J Ethics. 2019;21(9):E735-741. doi: 10.1001/amajethics.2019.735. Medicine and Society Sep 2019 Are Patients’ and Communities’ Poverty Exploited to Give Health Professions Students Learning Experiences? Harold W. Baillie, PhD and John F. McGeehan, MD Exploitation can be exacerbated when health professions students’ educational goals are overemphasized relative to patients’ and communities’ needs. AMA J Ethics. 2019;21(9):E801-805. doi: 10.1001/amajethics.2019.801. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
State of the Art and Science Aug 2019 Evolving Medicaid Coverage Policy and Rebates Jennifer A. Ohn, MPH and Anna Kaltenboeck, MA Ethics questions arise about the usefulness of a system that pegs Medicaid drug spending to net prices negotiated by others in the market. AMA J Ethics. 2019;21(8):E645-653. doi: 10.1001/amajethics.2019.645.
Policy Forum Aug 2019 Should a Law Governing the Pharmaceutical Market Be Ethically Examined Based on Its Intent or Its Practical Applications? Jordan M. Warchol, MD, MPH In 1984, Hatch-Waxman tried to balance drug innovation against availability; it was tested in the US Supreme Court in 2013. AMA J Ethics. 2019;21(8):E661-667. doi: 10.1001/amajethics.2019.661.
Policy Forum Aug 2019 Why Are Biosimilars Not Living up to Their Promise in the US? Mike Z. Zhai, Ameet Sarpatwari, JD, PhD, and Aaron S. Kesselheim, MD, JD, MPH Overall utilization of the few biosimilars currently available to patients has been limited. AMA J Ethics. 2019;21(8):E668-678. doi: 10.1001/amajethics.2019.668.
Medical Education Aug 2019 How Should Medical Education Better Prepare Physicians for Opioid Prescribing? Rohanit Singh and Gary W. Pushkin, MD Case-based teaching, longitudinal application, and training in ethical deliberation can better prepare physicians to responsibly prescribe and manage opioids. AMA J Ethics. 2019;21(8):E636-641. doi: 10.1001/amajethics.2019.636.
AMA Code Says Aug 2019 AMA Code of Medical Ethics’ Opinions Related to Prescription Drugs Rachel F. Harbut and Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics offers guidance on stewardship and professionalism. AMA J Ethics. 2019;21(8):E642-644. doi: 10.1001/amajethics.2019.642.
State of the Art and Science Aug 2019 Are Medicaid Closed Formularies Unethical? Leah Rand, DPhil and Govind Persad, JD, PhD Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients. AMA J Ethics. 2019;21(8):E654-660. doi: 10.1001/amajethics.2019.654.
Medical Education Sep 2019 Facilitating Critical Self-Exploration by Global Health Students William B. Ventres, MD, MA Awareness of one’s own interests is critical to successfully engaging in global health immersions. AMA J Ethics. 2019;21(9):E749-758. doi: 10.1001/amajethics.2019.749.
Policy Forum Sep 2019 How Should Public Health Schools Help Meet Millennium Development Goals in Latin America? Taryn Clark, MD, Julia Terle, MD, and Robert H. Gilman, MD Four MDGs directly concern public health, and public health schools should be involved in meeting them. AMA J Ethics. 2019;21(9):E788-795. doi: 10.1001/amajethics.2019.788.
Case and Commentary Sep 2019 What Are Criteria for Considering Technologies’ Uses and Influences in LMICs’ Health Care Infrastructures? Rolvix Patterson and Richard Rohrer, MD Low-resource areas are heterogeneous and changing, so establishing an evidence base for decision making about technology use is an important priority. AMA J Ethics. 2019;21(9):E735-741. doi: 10.1001/amajethics.2019.735.
Medicine and Society Sep 2019 Are Patients’ and Communities’ Poverty Exploited to Give Health Professions Students Learning Experiences? Harold W. Baillie, PhD and John F. McGeehan, MD Exploitation can be exacerbated when health professions students’ educational goals are overemphasized relative to patients’ and communities’ needs. AMA J Ethics. 2019;21(9):E801-805. doi: 10.1001/amajethics.2019.801.